Cancer Center “Near-Miss” NIH R01 Initiative supports principal investigators’ cancer research projects that narrowly missed NIH funding, aiming to help promising work secure external support.
Funder: Indiana Clinical and Translational Sciences Institute
Due Dates: Rolling (Notice of Intent) | Rolling after NOI approval (Full application)
Funding Amounts: Up to $50,000 for R01, R42, and R44 projects; P01 and SPORE amounts evaluated case by case
Summary: Supports cancer-focused NIH applications that narrowly missed funding and have strong potential to secure external support.
Key Information: Projects must first be submitted to the IU External Resubmission Grant opportunity and remain unfunded at the University level.
The IU Simon Comprehensive Cancer Center’s Near-Miss NIH R01 Initiative supports cancer-focused, principal investigator-directed research applications that have undergone NIH review but missed the NIH pay line. Listed through the Indiana Clinical and Translational Sciences Institute, the initiative aims to increase the cancer-focused NIH funding base by supporting projects with high potential to obtain external funding.
The opportunity encompasses R01, R42, and R44 grants, as well as P01 and SPORE applications. Cancer relevance is central to the program: applications directed to NIH institutes other than the National Cancer Institute must have significant cancer relevance.